Revelation Biosciences (REVB) Director Jennifer Carver Receives Award

What Happened
Jennifer Carver, a director of Revelation Biosciences, received a restricted stock award for 32,011 shares on August 17, 2026 (transaction code A). The reported acquisition price is $0.00, so the Form 4 shows $0 cash paid. The award was granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan.

Key Details

• Transaction date: 2026-08-17; Form 4 filed: 2026-08-18 (filed the next day, within the usual Form 4 reporting window).
• Price paid: $0.00; reported monetary value on Form 4: $0.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Grant/plan details: Award granted under the 2021 Equity Incentive Plan.
• Vesting: 50% vest at the two-year anniversary of the grant date and the remaining 50% vest at the four-year anniversary, subject to continued service; vesting may be accelerated if certain performance milestones are achieved.
• Transaction type: Award/grant (compensation), not an open-market purchase or sale.

Context
This is a compensation-related grant to a director (restricted stock) rather than a market purchase or sale—such awards are common and reflect compensation/retention rather than an immediate trading signal. Because the shares are restricted and vest over time (and may be performance-contingent), their economic value to the insider will depend on continued service and any milestone achievement; monitor future filings for vesting, acceleration events, or subsequent sales.